Table 2: Effect of antioxidant vitamins on lipid profile and atherogenic index.

Group TC (mg/dL)TG (mg/dL)HDL-C (mg/dL)LDL-C (mg/dL)VLDL-C (mg/dL)AI

I78.08 ± 4.0363.89 ± 5.1740.44 ± 5.3024.53 ± 4.8512.77 ± 1.030.61 ± 0.16
II123.64 ± 7.47c121.10 ± 12.14c30.36 ± 2.2369.05 ± 5.83c24.21 ± 2.42c2.27 ± 0.20c
III104.84 ± 6.96a, c76.08 ± 7.69 a43.72 ± 9.8245.80 ± 7.62a, c15.21 ± 1.54a1.08 ± 0.26a, d
IV101.52 ± 9.29a, c78.75 ± 3.19 a41.79 ± 6.08 b43.98 ± 5.26a, c15.74 ± 0.63a1.06 ± 0.18a, d
V97.21 ± 8.01a, c81.87 ± 13.86 a, d43.97 ± 11.46 b37.07 ± 9.93a, d16.16 ± 2.75a, d0.89 ± 0.34a
VI101.45 ± 6.22a, c86.12 ± 8.52a, c42.79 ± 2.86 b42.44 ± 4.27a, c17.22 ± 1.70a, c1.01 ± 0.12a, d

TC: total cholesterol, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, VLDL-C: very-low-density lipoprotein cholesterol, AI: atherogenic index, I: normotensive control, II: hypertensive control, III: group treated with vitamin C, IV: group treated with vitamin A, V: group treated with vitamin E, and VI: group treated with all the vitamins. Values are expressed as mean ± SD; . aP < 0.01 when compared with group II, bP < 0.05 when compared with group II, cP < 0.01 when compared with group I, and dP < 0.05 when compared with group I by Dunnette’s multiple comparison test.